Mostrar el registro sencillo del ítem

dc.contributor.authorRondy, Marc
dc.contributor.authorGherasim, Alin Manuel 
dc.contributor.authorCasado, Itziar
dc.contributor.authorLaunay, Odile
dc.contributor.authorRizzo, Caterina
dc.contributor.authorPitigoi, Daniela
dc.contributor.authorMickiene, Aukse
dc.contributor.authorMarbus, Sierk D
dc.contributor.authorMachado, Ausenda
dc.contributor.authorSyrjänen, Ritva K
dc.contributor.authorPem-Novose, Iva
dc.contributor.authorHorváth, Judith Krisztina
dc.contributor.authorLarrauri, Amparo 
dc.contributor.authorCastilla Catalán, Jesús
dc.contributor.authorVanhems, Philippe
dc.contributor.authorAlfonsi, Valeria
dc.contributor.authorIvanciuc, Alina E
dc.contributor.authorKuliese, Monika
dc.contributor.authorvan Gageldonk-Lafeber, Rianne
dc.contributor.authorGomez, Veronica
dc.contributor.authorIkonen, Niina
dc.contributor.authorLovric, Zvjezdana
dc.contributor.authorFerenczi, Annamária
dc.contributor.authorMoren, Alain
dc.date.accessioned2020-01-30T09:33:07Z
dc.date.available2020-01-30T09:33:07Z
dc.date.issued2017
dc.identifier.citationEuro Surveill. 2017 Oct;22(41).es_ES
dc.identifier.issn1560-7917es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8994
dc.description.abstractIn a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65-79-year-olds and 13% (95% CI: -15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.es_ES
dc.description.sponsorshipThe I-MOVE+ project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446. The Lithuanian I-MOVE+ study sites were supported by a grant from the Research Council of Lithuania (SEN-03/2015). We are grateful to all patients, medical staff, study nurses and epidemiologists from the 12 study sites who actively participated in the study.oin.es_ES
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectA(H3N2)es_ES
dc.subjectInfluenzaes_ES
dc.subjectCases controles_ES
dc.subjectElderlyes_ES
dc.subjectHospitalisationes_ES
dc.subjectVaccine effectivenesses_ES
dc.subject.meshAdolescent es_ES
dc.subject.meshAdult es_ES
dc.subject.meshAged es_ES
dc.subject.meshEuropean Union es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHospitalization es_ES
dc.subject.meshHospitals es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtype es_ES
dc.subject.meshInfluenza Vaccines es_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshOutcome Assessment, Health Care es_ES
dc.subject.meshSeasons es_ES
dc.titleLow 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasones_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID29043961es_ES
dc.format.volume22es_ES
dc.format.number41es_ES
dc.identifier.doi10.2807/1560-7917.ES.2017.22.41.17-00645es_ES
dc.contributor.funderUnión Europea 
dc.description.peerreviewedSíes_ES
dc.identifier.e-issn1560-7917es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDEuropean Union’s Horizon 2020 research and innovation programme under grant agreement No 634446es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEN-03/2015es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Nombre:
Low2016_17SeasonVaccine_2017.pdf
Tamaño:
125.8Kb
Formato:
PDF
Visualizar/Abrir

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional